CTLA4 and cancer: ICIs, including antibodies targeting programmed cell death protein 1 (PD-1), programmed death-ligand 1 (PD-L1), and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), unleash the immune system to recognize and attack cancer cells [24,25,26].